Patents by Inventor Francis Gerard

Francis Gerard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6284891
    Abstract: The present invention relates to a process for preparing camptothecin and camptothecin analogs of Formula (I) from compounds of Formula (II) and to novel intermediates useful in their preparation, wherein R1 to R6 represent various substituents.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: September 4, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Francis Gerard Fang, Shiping Xie
  • Patent number: 6143891
    Abstract: The present invention relates to a process for preparing camptothecin and camptothecin analogs of Formula (I) from compounds of Formula (II) and to novel intermediates useful in their preparation, ##STR1## wherein R.sub.1 to R.sub.6 represent various substituents.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: November 7, 2000
    Assignee: Glaxo Wellcome Inc.
    Inventors: Francis Gerard Fang, Shiping Xie
  • Patent number: 6063923
    Abstract: The present invention relates to a method for the preparation of camptothecin and camptothecin-like compounds and to novel intermediates used in this preparation. In particular, the invention provides a process for the preparation of the camptothecin derivative of formula (I') known by the chemical name "7-(4-methylpiperazino-methylene)-10,11-ethylenedioxy-20(R,S)-camptothecin ", which comprises cyclising the compound of formula (II'), wherein X is halogen, particularly chloro, bromo, or iodo; and when the compound of formula (I') is obtained as a mixture of enantiomers optionally resolving the mixture to obtain the desired enantiomer, and/or if desired, converting the resulting compound of formula (I') or a salt thereof into a physiologically acceptable salt or solvate thereof.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: May 16, 2000
    Assignees: Glaxo Wellcome Inc., North Carolina State University
    Inventors: Francis Gerard Fang, Edward McDonald Huie, Shiping Xie, Daniel L. Comins
  • Patent number: 5840898
    Abstract: A process for removal of heavy metal contaminants from organic compounds, especially campthothecin analogs.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: November 24, 1998
    Assignee: Glaxo Wellcome, Inc.
    Inventors: Francis Gerard Fang, Melissa Williams Lowery, Shiping Xie